Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1398 (LINC01398) is a member of the long intergenic non-coding RNA class, defined as autonomously transcribed RNA molecules longer than 200 nucleotides that do not overlap annotated protein-coding genes. LINC01398 does not encode a protein, and as of current knowledge, there is no established biological function, disease association, or therapeutic relevance reported for this gene. The broader class of lincRNAs may regulate gene expression, influence chromatin, and affect genome architecture, but the specific role of LINC01398 remains uncharacterized. No known drugs interact with LINC01398, and it is not currently considered a therapeutic target.
Not applicable; no drugs known to target LINC01398
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1398 (LINC01398).